Science and medicine typically move in spurts and stumbles.
Heres a rundown of this years drugs and innovations that are likely to be game-changers moving forward.
New weapons in the war against superbugs
Antibiotic resistance is one of humanitys greatest public health challenges.
Thanks to newly developed drugs like lenacapavir, we’re now closer than ever to ending the HIV epidemic.© bogubogu/Shutterstock
In October, the FDAapproveda drug designed to fight back against these hardy UTI bugs: Iterum Therapeutics Orlynvah.
In clinical trials, Cobenfy noticeably reduced peoples schizophrenia symptoms without causing major side effects.
Many outside scientists have already lauded the arrival of twice-yearly lenacapavir as theresearch breakthrough of the year.
While Aqneursa is taken alone, Miplyffa will be prescribed alongside an enzyme.
Miplyffas rollout also took longer, as the drug only becamecommercially available this month.
But given the lack of other options until now, these approvals are monumental.
The FDA still has to formally approve the drug, with a final decision expected by next July.
But given the compelling results, an approval appears very likely.
So the more options available for this condition, the better.
News from the future, delivered to your present.
Think It Takes 21 Days to Form a Habit?
